Three signal-driven stock theses every Sunday night (U.S. Eastern time) — each tracked with status, targets, and updates. Built from congressional trades, dark pool prints, and 13F data. For informational use only, not investment advice.
FREE WEEKLY RESEARCH IDEA — NO PAYMENT REQUIRED
Get Pick #1 free every Sunday
One complete research idea by email every Sunday night (8–10PM ET). No card required.
✓ Got it — thank you
Check back Sunday night for your free pick at whalequorum.com
Educational research only. Not investment advice. Unsubscribe any time.
4 independent data sources · AI-assisted analysis · Human reviewed every week ·
See a sample report →
4 Data Sources
Dark pool · Options · Congress · 13F — all public
Human Reviewed
Every report approved by a human before publishing
Weekly Cadence
One free idea every Sunday night — no daily noise
Price Mix
Under $5 to large cap — every account size covered
WHAT ARRIVES EACH SUNDAY NIGHT (8–10PM ET)
FREE — EVERY WEEK
One full research idea by email
✓Ticker and company overview
✓Signal breakdown — which data types fired
✓Research context from live web sources
✓Price at time of report — transparent
✓Price target, timeframe, and key risk
✓AI-assisted write-up — human reviewed
✓ Got it — thank you
Check back Sunday night for your free pick at whalequorum.com
PRO — $49/MONTH
Three full weekly ideas + full interpretation
✓Everything in Free — plus ideas #2 and #3
✓Full signal interpretation — why institutions are positioned here
✓Broader coverage — large cap, mid-cap, and under $50 ideas
✓Signal alerts when notable activity appears
✓Full archive access — every published report
✓Best for readers who want broader weekly coverage
7-day money-back guarantee · Cancel any time
✓ THIS IS FOR YOU IF
You want to understand what institutional data shows — not just opinions
You have limited time and want one curated weekly idea instead of a data firehose
You can evaluate research independently and make your own decisions
You trade stocks across any account size — we cover under $5 to large cap
✗ THIS IS NOT FOR YOU IF
You want guaranteed returns or specific buy/sell instructions
You need real-time intraday alerts — we publish weekly only
You are looking for personalized investment advice from a registered adviser
You cannot afford to lose the capital you invest — all investing carries risk
AI-ASSISTED RESEARCH · HUMAN REVIEWED
This Week's Signal-Driven Theses
Based on publicly available data · Published Sun Jul 26 · Each thesis tracked with status, targets and updates · Prices at publication only
Price at publication Sun Jul 26 · Not updated intraday
ST target: $390 · MT: $415 · LT: $445
Timeframe: Short 1-4wk · Medium 1-3mo · Long 3-12mo
Fresh CEO and director open-market buying gives ELV the cleanest insider-alignment signal in this week's field, coming two days after a Q2 earnings beat the stock still sold off against.
CEO INSIDER BUYCEO Gail Boudreaux bought 2,725 shares July 17 at $366.41–$368.25 (~$1.0M) · Director Steven Collis added 3,000 shares earlier this year (~$869,520) · Multi-insider accumulation, with recent buying outweighing reported sales in the current setup
EARNINGS CONTEXTQ2 2026 EPS $7.45 vs. $6.20 estimate, reported July 15 — a beat, but the stock declined into the CEO's July 17 buy
ANALYST CONSENSUSAnalyst target ranges generally cluster from the low $400s into the mid-$400s · stock down roughly 10% over the past week at time of insider buy
Thesis invalidated if: decisive break below the recent insider-buy range ($366-368) paired with deteriorating fundamentals, especially utilization or managed-care margin pressure. Key risks: healthcare regulation, reimbursement pressure, sector-wide de-rating even with insider support.
We will update this card every Sunday night until the thesis hits a target or is invalidated.
🔍 RESEARCH CONTEXT
Elevance's insider buying stands out because it's independently checkable: CEO Gail Boudreaux purchased 2,725 shares on July 17, 2026 at a weighted average of $367.79, an open-market transaction disclosed via Form 4, bringing her direct holdings to roughly 172,000 shares worth $63.5M. The purchase follows a stock decline of roughly 10% over the prior week. Director Steven Collis's earlier 2026 purchase adds a second insider data point. Analyst target ranges cluster around $400-$465. Research only, not investment advice.
SEC Form 4Yahoo FinanceInvesting.comQuiver Quantitative
🤖 AI-ASSISTED RESEARCH NOTE (Human reviewed)
"Based on publicly available data, Elevance Health's CEO and a director have both made open-market purchases in 2026, with recent buying outweighing reported sales — a rare multi-insider accumulation pattern. Combined with analyst targets well above the current price, this setup meets our confluence threshold. Educational research only — not investment advice."
⭐ PRO: SIGNAL INTERPRETATION — WHAT THE DATA SUGGESTS
"The institutional thesis on ELV centers on whether the multi-insider open-market buying cluster marks a durable floor after the post-earnings selloff, and how the healthcare sector's broader de-rating interacts with company-specific insider conviction..."
CEO INSIDER +35DIRECTOR CLUSTER +20ANALYST +15POST-EARNINGS +10
ST $390 · MT $415 · LT $445 · INVALIDATION $360
🔒
Research Ideas #2 & #3
One Pro subscription at $49/month unlocks both — not $49 each.
IDEA #2 · WATCHLIST
LOCKED
SPCX · SOFI · INTU
One subscription · Both ideas · Cancel any time
This week, only one setup cleared our full confluence and price-action test. SPCX's congressional signal was real, but the stock has since fallen more than 50% from its post-IPO peak and moved sharply against it — so it's on watchlist, not the pick slot. SOFI ($2.25M insider buying YTD) and INTU remain credible names on watch as well.
WATCHLIST
LOCKED
SPCX · SOFI · INTU
That is what the free weekly idea looks like.
Every Sunday night 8–10PM ET. No card required. Built from public market data and reviewed before publishing.
✓ Got it — check back Sunday night for your free pick
ABOUT WHALEQUORUM
Independent financial research newsletter
WhaleQuorum is an independent research newsletter that aggregates publicly available institutional market data and interprets it using AI-assisted analysis with mandatory human editorial review. We launched publishing in May 2026. Every report is written by AI and reviewed by a human editor before it reaches subscribers.
SEC STOCK Act disclosures weighted by committee relevance to the purchased sector
OPTIONS
Call sweeps bought on the ask above $500K premium indicate directional institutional positioning
13F
New positions and significant increases from top quantitative funds tracked quarterly
PLANS
Simple, transparent pricing.
Start free. One complete research idea every week, forever. Upgrade to Pro for all three with full analysis.
⚠️
Important: WhaleQuorum provides informational research only — not investment advice. All picks are based on publicly available data. Read full disclaimer ↓
Free
$0
forever · no card required
One full research idea every Sunday by email
1 complete research idea every Sunday night
Full signal breakdown for Idea #1
Mix of price ranges every week (under $50 to large cap)
Full AI-assisted analyst note
Price target + key risk
Weekly email delivery
Research ideas #2 & #3
Full historical database
✓ Got it — thank you
MOST POPULAR
Pro
$49
per month · cancel any time
$490/yr · save $98 · 2 months free
Three full weekly ideas, complete interpretation
All 3 research ideas every Sunday night (8–10PM ET)
Full AI-assisted analyst report per idea
Complete signal breakdown (dark pool + options + congress + 13F)
Full historical ideas database
✓ 7-day money-back guarantee · Cancel any time
LIVE THESIS TRACKER · UPDATED WEEKLY
Track Record
WhaleQuorum publishes weekly stock theses, not one-week promises. Every thesis is tracked with price at publication, time horizon, targets, risks, and status updates.
Published at $17.30. CEO Anthony Noto made 3 open-market purchases since March totaling ~$2.3M; director added ~$542K. Q2 earnings July 29 as catalyst.
⚠️ Earnings July 29 after close — binary event. Updated every Sunday night.
ISSUE #3 · PUBLISHED SUN MAY 17, 2026 · SUNDAY NIGHT
McGuire + Pelosi congressional cluster · Earnings catalyst May 20